Syn-2003

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameSyn-2003
Drug Alias Nameanti-angiogenic peptide (CLL Pharma)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCll Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCll Pharma
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A